RxDoctor Payments DataLook up a doctor →

Darin Gray, PA

Medical · Rock Hill, SCNPI 1619325990

Payments from drug & device makers

$16,172in general payments, 2019–2025

Across 868 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • UCB, Inc.$2K
  • LEO Pharma Inc.$2K
  • Johnson & Johnson$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Sun Pharmaceutical Industries Inc.$960
  • plus $5K from 22 others

What the payments were for

  • Food & beverage$15,37695%
  • Education$7965%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,172 in reported general payments places this provider in the 95th percentile of 384 medical providers in South Carolina.

See all medical providers in South Carolina

Medicare billing

Part B allowed, 2024
$142,267
Medicare patients
605
Services billed
2,950

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab76$298,942
Skyrizi PenRisankizumab-Rzaa12$246,924
Humira(Cf) PenAdalimumab18$142,210
OtezlaApremilast16$81,686
Clobetasol Propionate176$5,953
Tacrolimus53$5,794
Fluorouracil28$1,855
Betamethasone Dipropionate46$1,829
Clindamycin Phosphate36$1,514
Alclometasone Dipropionate24$1,379
Metronidazole28$1,336
Ketoconazole95$1,247
Desonide21$1,168
Triamcinolone Acetonide96$1,112
Doxycycline Hyclate47$1,026

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$436$81,68616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 384 medical providers in South Carolina.

Other medical in Rock Hill

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →